Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.
Article Details
- CitationCopy to clipboard
Luszczki JJ
Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.
Pharmacol Rep. 2009 Mar-Apr;61(2):197-216.
- PubMed ID
- 19443931 [ View in PubMed]
- Abstract
This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug interactions of novel (third-generation) antiepileptic drugs, including brivaracetam, carabersat, carisbamate, DP-valproic acid, eslicarbazepine, fluorofelbamate, fosphenytoin, ganaxolone, lacosamide, losigamone, pregabalin, remacemide, retigabine, rufinamide, safinamide, seletracetam, soretolide, stiripentol, talampanel, and valrocemide. These novel antiepileptic drugs undergo intensive clinical investigations to assess their efficacy and usefulness in the treatment of patients with refractory epilepsy.
DrugBank Data that Cites this Article
- Drugs